Effect of gammahydroxybutyric acid administration on catalepsy behaviour in female mice

Psicothema

Volumn 12, Issue 1, 2000, Pages 113-115

  Navarro, José Francisco ^a   Pedraza, Carmen ^b   Dávila, Guadalupe ^b   Martín López, Mercedes ^b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347649352     PISSN: 02149915     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Banerjee, P.K., Hirsch, E. and Snead, O.C. (1993). Gammahydroxybutyric acid induced spike and wave discharges in rats: relation to high-affinity [3H]gamma-hydroxybutyric acid binding sites in the thalamus and cortex. Neuroscience, 56, 11-21.
2. Beardsley, P.M. (1996). Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB). Psychopharmacology, 127, 315-322.
3. Cash, C.D. (1994). Gammahydroxybutyrate: An overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent. Neuroscience and Biobehavioral Reviews, 18, 291-304.
4. Gallimberti, L., Canton, G., Gentile, N., Cibin, M., Fadda, F., Ferri, M., Ferrara, S.D. and Gessa, G.L. (1989). Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet, 30, 787-789.
5. Galloway, G.P., Frederick, S.L., Staggers, F.E. Jr., Gonzáles, M., Stalcup, S.A. and Smith, D.E. (1997). Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction, 92, 89-96.
6. Hechler, V., Peter, P., Gobaille, S., Bourguignon, J.J., Schmitt, M., Ehrardt, J.D., Mark, J. and Maitre, M. (1993). Gamma-hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities. Journal of Pharmacology and Experimental Therapeutics, 264, 1406-1414.
7. Hoffman, D.C. and Donovan, H. (1995). Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability. Psychopharmacology, 120, 128-133.
8. Howard, S.G. and Feigenbaum, J.J. (1997). Effect of gamma-hydroxybutyrate on central dopamine release in vivo. A microdialysis study in awake and anesthetized animals. Biochemical Pharmacology, 53, 103-110.
9. Kaufmann, E.E., Porrino, L.J. and Nelson, T. (1990). Pyretic action of low doses of gamma-hydroxybutyrate in rats. Biochemical Pharmacology, 40, 2637-2640.
10. Kazandjian, A., Spiraki, C., Papadopoulou, Z., Sfikakis, A. and Varonos, D.D. (1988). Behavioural and biochemical effects of haloperidol during the oestrous cycle of the rat. Neuropharmacology, 27, 73-78.
11. Lammers, G.J., Arendts, J., Declerk, A.C., Ferrari, M.D., Schouwink, G. and Troost, J. (1993). Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study. Sleep, 16, 216-220.
12. Maitre, M. (1997). The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Progress in Neurobiology, 51, 337-361.
13. Martellotta, M.C., Fattore, L., Cossu, G. and Fratta, W. (1997). Rewarding properties of gamma-hydroxybutyric acid: an evaluation through place preference. Psychopharmacology, 132, 1-5.
14. Navarro, J.F. and Pedraza, C. (1996). An ethopharmacological assessment of the effects of gammahydroxybutyrate (GHB) on agonistic interactions in male mice. Medical Science Research, 24, 817-819.
15. Navarro, J.F., Manzaneque, J.M., Martín-López, M., Pedraza, C. and Dávila, G. (1996). Dose-dependent effect of gammahydroxybutyrate on catalepsy in mice. Medical Science Research, 24, 603-604.
16. Navarro, J.F., Manzaneque, J.M., Martín-López, M. and Vera, F. (1997). Daily versus intermittent haloperidol administration: effects on catalepsy of mice. Psicothema, 9, 83-87.
17. Navarro, J.F., Pedraza, C., Martín-López, M., Manzaneque, J.M., Dávila, G. and Maldonado, E. (1998). Tiapride-induced catalepsy is potentiated by gamma-hydroxybutyric acid administration. Progress in Neuropsychopharmacology & Biological Psychiatry, 22, 835-844.
18. Sanberg, P.R. (1980). Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors. Nature, 284, 472-473.
19. Schmidt, C., Gobaille, S., Hechler, V., Schmitt, M., Bourguignon, J.J. and Maitre, M. (1991). Anti-sedative and anti-cataleptic properties of NCS-382, a gamma-hydroxybutyrate receptor antagonist. European Journal of Pharmacology, 203, 393-397.
20. Schmidt, C., Pain, L., Sandner, G., Gobaille, S. and Maitre, M. (1998). The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil. European Journal of Pharmacology, 342, 21-27.
21. Snead, O.C. and Bearden, L.J. (1980). Naloxone overcomes the dopaminergic, EEG and behavioural effects of gammahydroxybutyrate. Neurology, 30, 832-838.
22. Tunnicliff, G. (1997). Sites of action of gamma-hydroxybutyrate (GHB). A neuroactive drug with abuse potential. Clinical Toxicology, 35, 581-590.
23. Van Cauter, E., Plat, L., Scharf, M.B., Leproult, R., Cespedes, S., L'Hermite, M. and Copinschi, G. (1997). Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gammahydroxybutyrate in normal young men. Journal of Clinical Investigation, 100, 745-753.
24. Waynford, H.B. and Flecknell, P.A. (1992). Experimental and surgical technique in the rat. New York, Academic Press.